ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

VTGN VistaGen Therapeutics Inc

4.55
0.14 (3.17%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
VistaGen Therapeutics Inc VTGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.14 3.17% 4.55 13:00:08
개장가 저가 고가 종가 전일 종가
4.47 4.31 4.55 4.50 4.41
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202421:30BWVistagen Announces Positive Results from Phase 2A Pilot..
09/04/202421:30BWVistagen to Present at the 2024 Anxiety and Depression..
01/04/202421:30BWVistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol..
11/03/202421:30BWVistagen to Present at Stifel 2024 Virtual CNS Days
07/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/03/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
28/02/202422:30BWVistagen to Present at TD Cowen 44th Annual Health Care..
15/02/202408:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202406:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/02/202422:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:52EDGAR2Form S-3 - Registration statement under Securities Act of..
14/02/202406:33EDGAR2Form 8-K - Current report
14/02/202406:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/02/202406:20BWVistagen Reports Fiscal 2024 Third Quarter Financial Results..
06/02/202422:30BWVistagen to Report Fiscal Year 2024 Third Quarter Financial..
04/01/202407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/01/202407:09EDGAR2Form 8-K - Current report
27/12/202322:30BWVistagen Receives Notice from European Patent Office of..
10/11/202306:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:42EDGAR2Form 8-K - Current report
10/11/202306:30BWVistagen Provides Corporate Update and Reports Fiscal 2024..
08/11/202322:30BWVistagen to Present at Stifel 2023 Healthcare Conference
07/11/202322:30BWVistagen to Present Positive Fasedienol Phase 3 Data and..
07/11/202311:46EDGAR2Form 8-K/A - Current report: [Amend]
07/11/202306:27EDGAR2Form 8-K - Current report
06/11/202322:00BWVistagen To Report Second Quarter Financial Results and Host..
04/11/202309:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/10/202305:13EDGAR2Form 8-K - Current report
17/10/202305:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/10/202305:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/10/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202305:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/10/202305:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
05/10/202321:30BWVistagen to Present at Jefferies Inaugural Biotech CNS/Neuro..
05/10/202305:07EDGAR2Form 8-K - Current report
04/10/202305:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
02/10/202320:30BWVistagen Announces Pricing of $100 Million Underwritten..
02/10/202320:15EDGAR2Form 8-K - Current report
30/09/202305:26EDGAR2Form 8-K - Current report
12/09/202321:30BWVistagen Announces Positive Results from Exploratory Phase..
09/09/202306:27EDGAR2Form 8-K - Current report
05/09/202322:00BWVistagen and Fuji Enter Exclusive Negotiation Agreement for..
24/08/202302:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202302:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/08/202321:40EDGAR2Form 8-K - Current report
22/08/202321:30BWVistagen Appoints Cindy Anderson as Chief Financial Officer

최근 히스토리

Delayed Upgrade Clock